GUGGENHEIM CAPITAL LLC - THERAVANCE INC ownership

THERAVANCE INC's ticker is THRX and the CUSIP is 88338T104. A total of 127 filers reported holding THERAVANCE INC in Q3 2014. The put-call ratio across all filers is 1.82 and the average weighting 0.1%.

Quarter-by-quarter ownership
GUGGENHEIM CAPITAL LLC ownership history of THERAVANCE INC
ValueSharesWeighting
Q4 2015$2,353,000
+19.8%
223,141
-18.4%
0.01%
+16.7%
Q3 2015$1,964,000
-86.6%
273,462
-66.2%
0.01%
-83.3%
Q2 2015$14,607,000
+47.6%
808,353
+28.4%
0.04%
+56.5%
Q1 2015$9,896,000
+42.8%
629,487
+28.5%
0.02%
+35.3%
Q4 2014$6,930,000
+27.9%
489,785
+54.4%
0.02%
+30.8%
Q3 2014$5,420,000
-17.1%
317,143
+44.4%
0.01%
-23.5%
Q2 2014$6,539,000
-11.3%
219,591
-7.9%
0.02%
-19.0%
Q1 2014$7,376,000
+15.9%
238,392
+33.5%
0.02%
+10.5%
Q4 2013$6,365,000
-14.5%
178,533
-2.0%
0.02%
-29.6%
Q3 2013$7,447,000
+305.6%
182,114
+282.2%
0.03%
+237.5%
Q2 2013$1,836,00047,6550.01%
Other shareholders
THERAVANCE INC shareholders Q3 2014
NameSharesValueWeighting ↓
Baupost Group 19,815,983$338,655,0005.90%
Litespeed Management, L.L.C. 2,670,695$45,642,0001.76%
CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD 2,790,913$47,697,0001.76%
Proxima Capital Management, LLC 915,000$15,637,0001.69%
IRIDIAN ASSET MANAGEMENT LLC/CT 8,196,372$140,076,0001.44%
PERRY CAPITAL 1,831,099$31,293,0001.14%
Roundview Capital LLC 140,145$2,395,0001.08%
SECTORAL ASSET MANAGEMENT INC 971,438$16,602,0000.70%
Realm Partners LLC 139,982$2,392,0000.68%
BB BIOTECH AG 743,244$12,702,0000.52%
View complete list of THERAVANCE INC shareholders